Clinical Trial

Comparison Between Low-Dose and High-Dose Nepafenac Sodium

Completed
View on ClinicalTrials.gov →
Summary
In South Punjab, Pakistan, where tertiary hospitals manage a high cataract workload, data on nepafenac sodium to reduce this inflammatory response is not up to the mark. Relative benefit of low-dose versus high-dose regimens remains unclear in routine clinical practice. Therefore, this study was performed with the objective to compare the effectiveness of low-dose nepafenac sodium with high-dose nepafenac sodium in preventing macular edema after cataract surgery.
Trial Details
NCT Number NCT07749027
Lead Sponsor Muhammad Aamir Latif
Conditions Cataract
Enrollment 176 participants
Start Date 2026-01-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-06